Top Players Covered in the US Genetic Testing Market Research Report Are Invitae Corporation (San Francisco, U.S.), Ambry Genetics (Aliso Viejo, U.S.), BioReference Laboratories, Inc. (Elmwood Park, U.S.), Progenity, Inc. (San Diego, U.S.), Quest Diagnostics Incorporated (Secaucus, U.S.), Myriad Genetics, Inc. (Salt Lake City, U.S.), Fulgent Genetics (Temple City, U.S.), Burning Rock Biotech Limited (Guangzhou, China) and other key market players.

Pune, India, May 17, 2021 (GLOBE NEWSWIRE) -- US Genetic Testing Market Size| 2021 Covid-19 Impact On Automotive Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2026 is latest study published by Fortune Business Insights. The US Genetic Testing Market size is expected to gain momentum by reaching USD 10.29 billion by 2027 while exhibiting an impressive CAGR of 13.0% between 2020 and 2027. This information is published by Fortune Business Insights in its latest report, titled, “U.S. Genetic Testing Industry, 2020-2027.” The report further mentions that the market stood at USD 4.11 billion in 2019. Factors such as increasing prevalence of chronic disorders and the increasing awareness regarding the efficacy of genetic testing in the U.S. will contribute to the growth of the market during the forecast period.

Global US Genetic Testing Market Highlights:

The US Genetic Testing Market report offers an in-depth analysis of the U.S. Genetic Testing industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, US Genetic Testing Market concentration, and maturity analysis is elaborated in this report.

Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.

Market to Exhibit 6.7% Growth in 2020 amid COVID-19

The market for genetic testing in the U.S. is expected to register a lower growth by exhibiting a CAGR of 6.7% in 2020. Factors such as cancellation and postponement of non-essential diagnostics such as that of hereditary disease and cancer screening and more impetus on COVID-19 screening is expected to lead to sluggish growth of the market. However, favorable government policies and proactive steps to widen the reach of screening amongst patients by the companies is expected to contribute to the growth of the U.S. Genetic Testing Industry in the forthcoming years.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/u-s-genetic-testing-market-105034

The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global US Genetic Testing Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.

Increasing Prevalence of Chronic Disorders to Augment Growth

According to the Centers for Disease Control and Prevention (CDC), chronic ailments such as cancer, heart disorders, and diabetes are the leading cause of disability and deaths of people across the U.S. Moreover, the U.S. healthcare system suffers an estimated USD 320 billion annually, in direct and indirect costs. Therefore, to reduce the healthcare costs, several healthcare companies contemplate offering advanced screening solutions to detect the disease at the preliminary stage and further prevent disease fatality. Moreover, increasing awareness regarding the efficacy of the genetic testing methods amongst the healthcare professionals is expected to favor the US Genetic Testing Market growth in the forthcoming years.

This report focuses on U.S. Genetic Testing Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2026, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.

Partnership between Major Companies to Amplify Their Market Positions

The market is fragmented by the presence of major companies such as Myriad Genetics and Quest Diagnostics trying to maintain a stronghold by partnering other companies to expand their product portfolio. Moreover, the other companies such as Ambry Genetics, Invitae Corporation, and BioReference Laboratories are adopting strategies such as merger and acquisition to maintain their presence and gain a competitive edge over their rivals in the forthcoming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/u-s-genetic-testing-market-105034

What does the Report Provide?

The market report provides a qualitative and quantitative analysis of the market and focuses on key aspects such as the regulatory overview, key industry developments such as mergers, acquisitions, and partnerships, and funding raised by start-up companies that will impact the market. Additionally, the report offers valuable insights into the latest market trends and highlights key industry dynamics by adopting several research methodologies during the forecast period.

Quick Buy - US Genetic Testing Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/105034

List of the Companies Profiled in the Market:

• Invitae Corporation (San Francisco, U.S.)

• Ambry Genetics (Aliso Viejo, U.S.)

• BioReference Laboratories, Inc. (Elmwood Park, U.S.)

• Progenity, Inc. (San Diego, U.S.)

• Quest Diagnostics Incorporated (Secaucus, U.S.)

• Myriad Genetics, Inc. (Salt Lake City, U.S.)

• Fulgent Genetics (Temple City, U.S.)

• Burning Rock Biotech Limited (Guangzhou, China)

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/u-s-genetic-testing-market-105034

Some major points from Table of Content:

• Introduction

  • Research Scope

  • Market Segmentation

  • Research Methodology

  • Definitions and Assumptions

• Executive Summary

• Market Dynamics

  • Market Drivers

  • Market Restraints

  • Market Opportunities

• Key Insights

  • Regulatory Overview

  • Overview: Funding Raised by Genetic Testing focused Start-up Companies

  • Key Industry Developments - Mergers, Acquisitions, and Partnership

  • Porter’s Five Forces Analysis

  • SWOT Analysis

  • Impact of COVID-19 Pandemic on the US Genetic Testing Market

  • Analysis of Transactions in the Molecular Diagnostic Clinical Laboratory Market

  • Overview: Personalized Medicine Market Size (USD billion), U.S., 2019

  • Reimbursement Scenario

• U.S. Genetic Testing Industry Analysis, Insights and Forecast, 2016-2027

  • Key Findings / Summary

  • Market Analysis, Insights and Forecast – By Technique

    • PCR

    • DNA Sequencing

    • Microarrays

    • Others

  • Market Analysis, Insights and Forecast – By Application

    • Cardiology

    • Oncology

    • Pharmacogenomics

    • Cognitive Dysfunction

    • Pathogenomics

    • Others

  • Market Analysis, Insights and Forecast – By Payer

    • Public Health Insurance

    • Private Health Insurance

    • Out-of-Pocket

  • Market Analysis, Insights and Forecast – By End User

    • Hospitals

    • Independent Laboratories

• Competitive Analysis

• • U.S. Market Share Analysis (2019)

  • Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based On Availability))

• • • Invitae Corporation

    • Ambry Genetics

    • BioReference Laboratories, Inc.

    • Progenity, Inc.

    • PathemaGX

    • Quest Diagnostics Incorporated

    • Myriad Genetics, Inc.

    • Fulgent Genetics

    • Burning Rock Biotech Limited

Continued...

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/u-s-genetic-testing-market-105034

Have a Look at Related Reports:

Ophthalmic Lasers Market Size, Share and Industry Analysis By Type (Excimer Lasers, Femtosecond Lasers, Nd Yag Lasers, Diode Lasers), Technology (Photodisruption, Selective Laser Trabeculoplasty, Photocoagulation), Application (Cataract Treatment, Glaucoma Treatment, Refractive Errors Treatment), End-User (Ophthalmic Laser Centers,Hospitals ) & Regional Forecast, 2019 – 2026

Hiv/Aids Drugs Market Size, Share and Industry Analysis By Drug Class (Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs), Integrase Inhibitors, Combination HIV Medicines, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027

Gene Therapy Market Size, Share & COVID-19 Impact Analysis, By Application (Oncology, Neurology, and Others), By Vector Type (Viral and Non-viral), By Distribution Channel (Hospitals, Clinics, and Others), and Regional Forecast, 2020-2027

Vitamin D Testing Market Size, Share and Industry Analysis By Product (25 -Hydroxy Vitamin D Testing, 1,25-Dihydroxy Vitamin D Testing, 24,25-Dihydroxy Vitamin D Testing), By Application (Clinical Testing, Research Testing), By End User (Diagnostic Laboratories, Hospitals & Clinics, Others), and Regional Forecast 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs